Talha Badar, M.D.

  1. Hematologist / Oncologist
  • My long term goal is to understand molecular mechanisms underlying myeloid disorders/leukemia and to develop innovative strategies to improve its clinical outcome.
  • My interest in leukemia and myeloid disorders is derived from years of clinical training.
  • Training in different hospitals and different countries helped me to developed diverse clinical perspective to solve important clinical problems.
  • My aim is to provide compassionate care to my patients with best of my abilities, empowering them to make rationalized decision.

My interest is in acute leukemia, myeloid disorders and cellular therapy.

  1. 2020
    Fellowship - Hematology and OncologyMedical College of Wisconsin
  2. 2017
    Residency - Internal MedicineBrandon Regional Hospital
  3. 2015
    Fellowship - Clinical LeukemiaUniversity of Texas MD Anderson Cancer Center
  4. 2013
    Fellowship - Medical OncologyCollege of Physicians and Surgeons Pakistan
  5. 2009
    Residency - Internal MedicineCollege of Physicians and Surgeons Pakistan
  6. 2006
    MBBSJinnah Medical and Dental College

Certifications

  1. 2020
    HematologyAmerican Board of Internal Medicine
  2. 2020
    Medical OncologyAmerican Board of Internal Medicine
  3. 2017
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2019
    Outstanding Fellow Research Award at Wisconsin Association of Hematology and Oncology (WAHO) Annual Meeting 2019.Wisconsin Association of Hematology and Oncology (WAHO)
  2. 2017
    Best Resident Research Award, presented at Presented at HCA West Florida GME Consortium/Brandon Regional Hospital Annual Research Day, 2017.HCA West Florida GME Consortium/Brandon Regional Hospital
  3. 2017
    People’s Choice Award for best research at Health Corporation of America West Division Annual Research Day, 2017.Health Corporation of America West Division
  4. 2015
    Future Leaders Award for Clinical Research in Hematology Celgene
  5. 2014
    Best Abstract Achievement Award, presented at American Society of Hematology Annual Meeting, 2014.American Society of Hematology
  6. 2014
    Best oral abstract “Outcome of FLT3 ITD Mutated AML Patients Based on Different Treatment Strategies”. Presented at Society of Hematology Oncology Annual meeting 2014, Houston, Texas, USA.Society of Hematology and Oncology
  7. 2004
    Final Professional Annual: Distinction in Surgery and ENT and Overall Class Rank: SecondJinnah Medical and Dental College
  8. 2003
    Third Professional Annual: Distinction in Community Medicine and Overall Class Rank: Second.Jinnah Medical and Dental College
  9. 2002
    Second Professional Annual: Overall Class Rank: Third.Jinnah Medical and Dental College
  10. 2001
    First Professional Part B: Distinction in Biochemistry, Physiology and Anatomy with Overall Class Rank: First.Jinnah Medical and Dental College
  11. 2000
    First Professional Part A: Distinction in Biochemistry, Physiology and Anatomy with Overall Class Rank: Third.Jinnah Medical and Dental College

Professional memberships

  1. 2021 - present
    MemberScientific Review Committee A, Mayo Clinic Cancer Center
  2. 2021 - present
    Associate MemberMayo Clinic Cancer Center
  3. 2021 - present
    Associate Board MemberMayo Clinic Comprehensive Cancer Center
  4. 2020 - present
    Member-at-LargeFlorida Society of Clinical Oncology
  5. 2020 - present
    InvestigatorNational Cancer Institute, National Institutes of Health
  6. 2017 - present
    Committee MemberCIBMTR Acute Leukemia Working Committee
  7. 2017 - present
    Committee MemberCIBMTR Chronic Leukemia Working Committee
  8. 2017 - present
    Committee memberCIBMTR Cellular Therapy Working Committee Member
  9. 2017 - present
    MemberAmerican Society of Hematology
  10. 2017 - present
    Committee Member and Reviewer, Futures Grants InvestigatorCenter for International Blood and Marrow Transplant Research (CIBMTR)

Publications